№ files_lp_3_process_7_072759
File format: docx
Character count: 9380
File size: 34 KB
Leitfaden einer Pflegeeinrichtung zur rechtlichen und fachlichen Vorgehensweise bei verdeckter Medikamentengabe an nicht einwilligungsfähige Personen unter Berücksichtigung von Entscheidungsprozessen, Beteiligung relevanter Akteure und umfassender Dokumentation.
Organisation:
Care Home
Thematik:
Verwaltung von Medikamenten ohne Wissen oder Zustimmung
Dokumenttyp:
Leitfaden
Rechtsgrundlage:
Mental Capacity Act 2005
Zielgruppe:
Pflegepersonal, verschreibende Ärztinnen und Ärzte, multidisziplinäre Teams
Beteiligte Stellen:
Verschreibende Fachkraft, verantwortliche Person der Pflegeeinrichtung, Apotheker, Angehörige, Betreuer, Independent Mental Capacity Advocate
Bezug auf Aufsichtsbehörde:
Care Quality Commission
Geltungsbereich:
Pflegeeinrichtungen
Verfahrensschritte:
Mental Capacity Assessment, Best-Interest-Entscheidung, Prüfung der Arzneimitteleignung, Dokumentation
Besondere Anforderungen:
Letztes Mittel, medikationsspezifisch, zeitlich begrenzt, regelmäßig überprüft, transparent, inklusiv, im besten Interesse der betroffenen Person
Dokumentationspflicht:
Verpflichtend, fortlaufend zu aktualisieren und überprüfbar
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2020
Region / city:
India
Topic:
Mental health care, long-stay psychiatric services, Mental Healthcare Act 2017
Document Type:
Clinical guidelines
Organization / institution:
National Institute of Mental Health and Neurosciences (NIMHANS), JNU Medical College
Author:
Prakyath Ravindranath Hegde, Manaswi Gautham, Channaveerachari Naveen Kumar, Narayana Manjunatha, Suresh Bada Math
Target audience:
Healthcare professionals, mental health establishments, stakeholders in psychiatric care
Period of validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Note:
Year
Subject:
Medicine Administration
Document Type:
Procedure
Target Audience:
Care Home Staff, GP, MOCH, Pharmacists, Next of Kin
Year:
2024
Region / City:
Cayuga County
Topic:
Environmental Projects, Water Quality Management
Document Type:
Grant Application, Project Update
Author:
Not specified
Target Audience:
Town officials, environmental agencies, project stakeholders
Period of Activity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / city:
Australia
Subject:
Pharmaceutical compounding guidelines
Document Type:
Guideline
Organization / Institution:
Pharmacy Board of Australia
Author:
Pharmacy Board of Australia
Target Audience:
Registered pharmacists, education providers, employers
Period of validity:
Indefinite
Approval Date:
Not specified
Date of amendments:
Not specified
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Organisation:
Canberra Health Services
Document type:
Guideline
Reference number:
CHS25/225
Jurisdiction:
Australian Capital Territory
Healthcare setting:
Public health services
Subject area:
Medication management
Professional scope:
Nursing and midwifery practice
Approved by:
Drug and Therapeutics Committee
Target professionals:
Registered nurses and registered midwives
Patient groups:
Adults, children 12 years or older, and selected medicines for children under 12 years
Exclusions:
Neonates, Special Care Nursery patients, Neonatal Intensive Care Unit patients
Regulatory framework:
Australian medicines scheduling (Schedules 2, 3, 4, and 8)
Content components:
Governance, safe use, documentation, approved medicine lists
Year:
2023
Region / city:
European Union
Topic:
Pharmaceutical technology development
Document type:
Briefing document
Organization:
European Medicines Agency
Author:
Not specified
Target audience:
Pharmaceutical experts, regulatory authorities
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
This document is a briefing source for discussing pharmaceutical technology and regulatory aspects at a QIG 1:
1 meeting.
Year:
2023
Country:
Australia
Topic:
Opioid dependence treatment
Document type:
Information overview
Program:
ODT Community Pharmacy Program
Administering body:
Pharmacy Programs Administrator
Related scheme:
Pharmaceutical Benefits Scheme
Legislative framework:
National Health (Highly specialised drugs program) Special Arrangement 2021
Target audience:
Community pharmacists and hospital pharmacists
Effective date:
1 July 2023
Funding period:
2023–24 to 2026–27
Medicines covered:
Methadone, buprenorphine, buprenorphine with naloxone
Regulatory classification:
Schedule 8 controlled drugs
Source type:
Government health program guidance
Document type:
Q&A guidance
Jurisdiction:
Japan
Subject:
Import and shipment of medicines and medical devices
Issuing authority:
Ministry of Health, Labour and Welfare
Intended users:
Individuals importing or sending medicines for personal use
Scope:
Prescription medicines, injections, syringes, and medical devices
Import purpose:
Personal use
Regulatory framework:
Pharmaceutical and Medical Device regulations
Application system:
Online Import Confirmation system
Related forms:
Import Confirmation Application Form (Form 12); Explanation of Pharmaceutical Product (Form 13)
Year:
2024
Region / city:
Denmark
Topic:
Medicine, Health Economics
Document type:
Template
Organization / institution:
Danish Medicines Council
Author:
Danish Medicines Council
Target audience:
Pharmaceutical companies
Period of validity:
Ongoing
Approval date:
10 September 2024
Date of changes:
1 April 2025
Version:
2.5
Year:
2021
Region / city:
Victoria, Australia
Theme:
Pharmacist regulations
Document type:
Legislative guideline
Agency / institution:
Medicines and Poisons Regulation (MPR)
Author:
Medicines and Poisons Regulation (MPR)
Target audience:
Health practitioners, pharmacists
Period of validity:
Ongoing
Approval date:
2017
Date of amendments:
2021
Context:
This document provides guidelines for pharmacists regarding the dispensing, administration, and supply of Schedule 4 and 8 medicines in Victoria, Australia, as outlined in the Drugs Poisons and Controlled Substances Act 1981 and related regulations.
Year:
2020
Region / city:
UK
Theme:
Medicines Information
Document type:
List
Organization / institution:
NHS
Author:
UKMi
Target audience:
NHS Medicines Information Services
Period of validity:
Ongoing, updated quarterly
Approval date:
November 2020
Date of changes:
May 2020
Note:
Year
Subject:
Medicine Formularies, Health Policy
Document Type:
Form, Application
Institution:
Ministry of Health
Author:
Applicant (Consultant, Specialist, Medical Officer, Pharmacist)
Target Audience:
Healthcare Professionals, Drug and Therapeutic Committee
Context:
Form used to propose the inclusion of a medicine or indication from the Ministry of Health Medicines Formulary into an institution’s Medicines Formulary for approval by the institution’s Drug and Therapeutic Committee.
Year:
Not specified
Region / City:
Malaysia
Topic:
Pharmaceutical registration and formulary listing
Document Type:
Application Form
Organization / Institution:
Ministry of Health Malaysia
Author:
Not specified
Target Audience:
Pharmaceutical companies, regulatory authorities
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Topic:
Health, Pharmaceuticals
Document Type:
Informational Resource
Organization / Institution:
U.S. Food and Drug Administration
Target Audience:
Consumers, Healthcare Providers, Information Professionals, Researchers
Year:
2018
Region / City:
Wellington, New Zealand
Topic:
Medicine administration
Document type:
Guideline
Organization / Institution:
New Zealand Nurses Organisation
Author:
New Zealand Nurses Organisation
Target audience:
Nurses, midwives
Period of validity:
Not specified
Approval date:
2018
Date of changes:
Not specified
ISBN:
978-1-877461-66-8
Year:
[insert date of swearing]
Jurisdiction:
High Court
Document type:
Oath and Bond
Subject:
Estate administration of deceased
Deceased name:
[insert all variations of the name]
Deceased address:
[insert address]
Date of death:
[insert date]
Place of death:
[insert place]
Applicant name:
[insert name]
Applicant address:
[insert address]
Gross value of estate:
[insert value]
Administrator relationship to deceased:
[state relationship]
Witnessed by:
Commissioner for Oaths / Practising Solicitor
Filing:
Filed with High Court on [insert date]
Year:
2012
Region / city:
Portland, OR
Topic:
Professional Planning Services, Kuali Coeus Research Administration System
Document type:
Request for Quotations
Organization / institution:
Portland State University
Author:
Not specified
Target audience:
Vendors, contractors
Effective period:
N/A
Approval date:
August 17, 2012
Amendment date:
N/A